Download Docs
Export

MEPACT

79202391 | Trademark

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Dec. 16, 2016
Serial No. 79202391
Registered Aug. 8, 2017
Registration No. 5,258,435
Examining Attorney SHAILA SETTLES LEWIS
Class Chemicals for preparations for medical or veterinary use, namely, muramyl peptides and muramyl tripeptides, muramyl tripeptide phosphatidyl ethanolamine (MTP-PE), Nacetylmuramyl- L-alanyl-D-isoglutaminyl-L-alanine-2-(1,2- dipalmitoyl-sn-glycero-3-hydroxyphosphoryloxy)-ethylamide, hexopyranose and formulations of muramyl peptides, namely, liposomal formulations, pharmaceutically acceptable forms of muramyl peptides, pharmaceutically acceptable salts of muramyl peptides, all of these products being more specifically meant to be used for anti-cancer therapy, antiviral therapy, neoplasia and pathologies induced by chemotherapy, namely, mucositis, myelosuppression, peripheral neuropathy; pharmaceutical preparations, namely, for anti-cancer and antiviral therapies, neoplasia, and pathologies induced by chemotherapy, namely, mucositis, myelosuppression, peripheral neuropathy; 006; 018; 044; 046; 051; 052
MEPACT
Case Type Trademark
Status A Section 71 and 15 declaration has been accepted and acknowledged.
Last Updated: 1 year, 8 months ago
Filing Date # Docket Text